Substrate Targeting Mechanisms of Nedd4 Family Ubiquitin Ligases
Substrate Targeting Mechanisms of Nedd4 Family Ubiquitin Ligases
批准号:
8786568
负责人:
Jason A MacGurn
金额:
$24.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-06-01 至 2016-11-30
关键词:
AccountingAdaptor Signaling ProteinAddressAffectApoptosisArrestinsAttenuatedAutoimmune DiseasesAutoimmunityBacteriaBiological AssayBreast Cancer CellBreast Cancer TreatmentC-terminalCancer Cell GrowthCell membraneCell surfaceChemicalsDevelopmentDiseaseDrug TargetingEndocytic VesicleEndocytosisEpidermal Growth Factor ReceptorEventExcisionFamilyFutureG-Protein-Coupled ReceptorsGoalsGrowthHealthHumanHuman GenomeHypertensionIn VitroInvestigationLeadLigandsLinkMalignant NeoplasmsMammalian CellMass Spectrum AnalysisMediatingMembrane ProteinsModelingMolecularMolecular TargetN-terminalNormal CellPhosphorylationPhosphorylation SiteProtein FamilyProteinsProteomicsReactionRegulationResearchResearch PersonnelRoleSignal TransductionSite-Directed MutagenesisSorting - Cell MovementStimulusSystemTherapeuticUbiquitinUbiquitinationVesicleWorkYeast Model SystemYeastscancer therapyendosome lumenhigh throughput screeninghuman diseaseimprovedin vivoinhibitor/antagonistinsightinterestknock-downmalignant breast neoplasmnovelnovel therapeuticsreceptorreconstitutionresearch studysignal processingtechnology developmenttherapeutic targettooltraffickingtumorigenesisubiquitin ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Many human diseases result from aberrant activity of proteins at the cell surface, including cancer,
hypertension, and autoimmune disorders. Normal cells control the abundance and activity of proteins at the
cell surface through a variety of mechanisms that regulate both the delivery of proteins to the plasma
membrane (PM) and removal of proteins from the PM. One of the primary removal mechanisms involves
conjugation to ubiquitin, a modification that targets PM proteins for sorting into vesicles which are then
internalized by endocytosis. I am interested in understanding the substrate targeting mechanisms that drive
ubiquitin-mediated endocytosis and my long-term goal as an independent researcher is to determine how
these mechanisms contribute to human disease.
This research plan proposes to investigate the substrate targeting mechanisms of Nedd4 family
ubiquitin ligases, which are critical for ubiquitin-mediated endocytosis and are implicated in many human
diseases. While human Nedd4 family ubiquitin ligases remain poorly understood, more is known about the
function of a Nedd4 family ubiquitin ligase in yeast called Rsp5. The critical role of Rsp5 as a regulator of
ubiquitin-mediated endocytosis is well-established, in part due to the powerful experimental tools available in
the yeast model system. The experimental strategy proposed here combines a detailed investigation of
substrate targeting mechanisms of Rsp5 in yeast with a parallel strategy for the investigation of substrate
targeting of WWP1, a Nedd4 family ubiquitin ligase linked to human breast cancer. This will involve the
development of new experimental tools to facilitate the study of ubiquitin ligase substrate selection both in vitro
and in vivo.
Aim 1 of this research plan outlines a strategy for determining how phosphorylation regulates the
function of Rsp5 substrate adaptor proteins in yeast. This research has potentially significant implications for
Nedd4 family proteins in humans because the phosphorylation sites are conserved in mammalian arrestin
proteins, which are known to function as adaptors for Nedd4 ubiquitin ligases. Aim 2 describes a strategy to
investigate the inhibitory function of a class of Rsp5-interacting proteins. Although negative regulators of
Nedd4 family ubiquitin ligases have not been described in humans, this research could lead to the
development of novel therapeutic strategies for activating or inactivating Nedd4 ubiquitin ligase function. Aim 3
outlines a plan, influenced by mechanistic insights from Rsp5 in yeast, to identify the WWP1-mediated
ubiquitination event that facilitates breast cancer cell growth. These experiments in mammalian cells will
ultimately address the therapeutic potential of WWP1 as a molecular target for treatment of breast cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering the ubiquitin code in stress signaling and membrane trafficking
-
批准号:10330680
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2022
-
负责人:Jason A MacGurn
-
依托单位:
Deciphering the ubiquitin code in stress signaling and membrane trafficking
-
批准号:10557826
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2022
-
负责人:Jason A MacGurn
-
依托单位:
The Role of Ubiquitin Phosphorylation in Cellular Aging
-
批准号:9165414
-
项目类别:
-
资助金额:$22.13万
-
财政年份:2016
-
负责人:Jason A MacGurn
-
依托单位:
The Role of Ubiquitin Phosphorylation in Cellular Aging
-
批准号:9322424
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2016
-
负责人:Jason A MacGurn
-
依托单位:
Molecular Mechanisms for Regulation of Ubiquitin Metabolism
-
批准号:9252906
-
项目类别:
-
资助金额:$3.24万
-
财政年份:2016
-
负责人:Jason A MacGurn
-
依托单位:
Substrate Targeting Mechanisms of Nedd4 Family Ubiquitin Ligases
-
批准号:8279635
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2012
-
负责人:Jason A MacGurn
-
依托单位:
Substrate Targeting Mechanisms of Nedd4 Family Ubiquitin Ligases
-
批准号:8474635
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2012
-
负责人:Jason A MacGurn
-
依托单位:
Substrate Targeting Mechanisms of Nedd4 Family Ubiquitin Ligases
-
批准号:8776479
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2012
-
负责人:Jason A MacGurn
-
依托单位: